Our patients in Virginia Beach often report not just losing weight, but also gaining energy and confidence
[PubMed] [Google Scholar] [47].Thum A, Hupe-Sodmann K, Goke R, Voigt K, Goke B, McGregor GP, Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and 4, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 110 (2002) 113118
Additionally, it slows gastric emptying, keeping food in the stomach longer to increase fullness and reduce appetite
Since it also bypasses your digestive system, its another reliable choice for women on GLP-1 medications
The maintenance dose of Wegovy ranges between 0.5 mg and 2.4 mg
However, GLP-1, in addition to various GLP-1R agonists, is a 300-fold stronger inducer of GSIS (4, 9) and does not produce the effects of glucagon to increase hepatic glucose production, which is thought to be a key pathogenic driver of T2DM (3)